's Information

Young-Hak Kim, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. AI and Robotics for Cardiovascular Care
  2. Application of AI and Robotics for Cardiovascular Care
  3. Utilization of CT-Based Myocardial Segmentation
  4. CT-Based Myocardial Segmentation: Novel Method and Clinical Implication
  5. CT-Based Functional Imaging
  6. Invited Case Presentation & Focus Review: Left Main
  7. Lessons from CROSS and PERFECT Randomized Studies
  8. What Is Different for LM vs. with Non-LM Bifurcations
  9. No, What the Matter Is Not the Stenting Technique
  10. Key Messages of CROSS and PERFECT Trials: Prognostic Factors and Mechanisms
  11. CT-Perfusion
  12. Perfusion CT: One Stop Shop for Structure and Perfusion
  13. Access Complication and Bleeding
  14. [Noninvasive Tests Before Cath: Simple & Better] CT Myocardial Perfusion Imaging: One-Stop Shop for Structure & Function
  15. [Debates: SYNTAX, Clinical SYNTAX, and SYNTAX 2... Is It Mandatory Before LM Revascularization?] No, I Do Not Have Time.
  16. CROSS and PERFECT Trials: Impact of Kissing Balloon (vs. No Kiss) and 2-Stent (vs. 1-stent) Technique for Bifurcations
  17. Outcomes of PCI vs. CABG: Current and Future
  18. Key Lessons from CROSS and PERFECT Trial
  19. CT-Perfusion
  20. Qualitative and Quantitative Angiographic Evaluation of Bifurcation Lesion
  21. Outcomes of Second-generation DES for LM
  22. Perfusion CT
  23. Taped Lives: Implantation of CoreValve, Transfemoral
  24. Still Unsolved Issue: Bifurcation Lesion
  25. Outcome Mapping: Techniques, Devices & Skills
  26. Meta-analysis: PCI vs. CABG for Unprotected LM Stenosis
  27. When Should We Consider TAVI Procedure in Korea (Interventionist's Viewpoint)?
  28. Current Status of CROSS and PERFECT Study
  29. Second-generation DES for LM: PRECOMBAT-2
  30. Ischemia-guided Revascularization for Stable Angina Patients
  31. Ischemia-guided Optimal Revascularization
  32. Angiographic Limitation in LM and Bifurcation Interpretation
  33. [Debate: Incomplete/Complete and Functional/Anatomical Revascularization] Incomplete Revascularization Is Enough.
  34. Inability of AV Cross
  35. The Use of Nobori in Bifurcation
  36. K Xience Registry Results
  37. Periprocedural Patient management
  38. Impact of Complete Revascularization Strategy
  39. How to Improve Outcomes: Prognostics Factors of Bifurcation Stenting
  40. Current Challenges in Left Main Disease
  41. Guidelines and Current Practice in the Management of ACS Patients
  42. Anatomical and Functional Approach for Bifurcation PCI: Lessons from CROSS and PERFECT Trial
  43. Responsibilities of Investigators in Clinical Trials: From Consent to Safety Reporting
  44. New Bifurcation Trials of CROSS and PERFECT Trial Based on Functional and Anatomical Evaluation
  45. Can High Risk of LM Revascularization Be Identified with Preoperational Clinical and Angiographic Characteristics?: LM-SCORE
  46. Fundamental and QCA Measurement
  47. Angiographic Features of Bifurcation Coronary Lesions
  48. Risk Stratification of Left Main Revascularization
  49. DES for Complex Left Main: Experience in Columbia University
Conference Slides
Category